Company intelligence / Profile preview

GeneOne DASA

Ownership: Private
Employees: ~150
Development stage: Other

Overview

GeneOne Life Science is a South Korean biopharmaceutical company specializing in the development and manufacturing of nucleic acid-based therapies and vaccines. The company focuses on DNA vaccines for infectious diseases and small molecule treatments for inflammatory conditions, such as chronic sinusitis and idiopathic pulmonary fibrosis. Through its subsidiary, VGXI, GeneOne provides contract manufacturing services for plasmid DNA used in gene therapies and vaccines globally. Their clinical pipeline includes candidates for COVID-19, MERS, and Zika virus, leveraging a proprietary DNA delivery platform.

Therapeutic areas: Infectious DiseasesPulmonology
Modalities: DNA vaccineBiologicSmall moleculemRNA-based drugs
Industry: Biotech

Partnerships

Inovio PharmaceuticalsWistar InstituteDasa

Beyond the preview

Go deeper on GeneOne DASA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneOne DASA.

Explore the full profile